Balchem Corporation (NASDAQ:BCPC) reported a slight earnings miss but achieved record third-quarter sales, indicating robust growth.The company's financial metrics, including a P/E ratio of 34.56 and a debt-to-equity ratio of 0.15, reflect strong investor confidence and conservative debt use.Despite the positive financial performance, Balchem's stock has remained relatively stagnant, suggesting that investors are waiting for further results.Balchem Corporation, trading as NASDAQ:BCPC, is a key player in the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission file number: 1-13648 _____________________________________________________________________________________________________________ ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Balchem (BCPC) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.74%. A quarter ago, it was expected that this chemical company would post earnings of $1.25 per share when it actually produced earnings of $1.27, delivering a surprise of +1.6%.Over the last four quarters, the company ...

Key Points Balchem reported record third-quarter sales. The company is growing sales while also supporting new growth initiatives. 10 stocks we like better than Balchem › Many people may not know Balchem (NASDAQ: BCPC). The company works to find solutions to problems facing the nutrition, health, and food markets. The human and animal nutrition product company just reported record third-quarter sales, and the stock is jumping today. Balchem shares rose over 5% this morning and remained higher by 3 ...

Balchem (NasdaqGS:BCPC) Q3 2025 Earnings Call October 21, 2025 11:00 AM ET Company ParticipantsMartin Bengtsson - CFOTed Harris - Chairman, President, and CEOConference Call ParticipantsBob Labick - AnalystDaniel Harriman - Equity Research AnalystRam Selvaraju - Senior Healthcare AnalystMartin BengtssonI will now turn the call over to Ted Harris, our Chairman, President, and CEO.Ted HarrisThanks, Martin. Good morning and welcome to our conference call. We were extremely pleased with the financial results fo ...

Balchem (NasdaqGS:BCPC) Q3 2025 Earnings Call October 21, 2025 11:00 AM ET Company ParticipantsMartin Bengtsson - CFOTed Harris - Chairman, President, and CEOConference Call ParticipantsBob Labick - AnalystDaniel Harriman - Equity Research AnalystRam Selvaraju - Senior Healthcare AnalystMartin BengtssonI will now turn the call over to Ted Harris, our Chairman, President, and CEO.Ted HarrisThanks, Martin. Good morning and welcome to our conference call. We were extremely pleased with the financial results fo ...

Balchem (NasdaqGS:BCPC) Q3 2025 Earnings Call October 21, 2025 11:00 AM ET Speaker0I will now turn the call over to Ted Harris, our Chairman, President and CEO.Speaker1Thanks, Martin. Good morning, and welcome to our conference call. We were extremely pleased with the financial results for the 2025 and the strong performance of our company, fueled by the ongoing market penetration of our unique portfolio of specialty nutrients and delivery systems and the favorable better for you trends within the food and ...

Balchem (NasdaqGS:BCPC) Q3 2025 Earnings Call October 21, 2025 11:00 AM ET Speaker2I will now turn the call over to Ted Harris, our Chairman, President, and CEO.Speaker1Thanks, Martin. Good morning and welcome to our conference call. We were extremely pleased with the financial results for the first quarter of 2025 and the strong performance of our company, fueled by the ongoing market penetration of our unique portfolio of specialty nutrients and delivery systems, and the favorable better-for-you trends wi ...